Literature DB >> 1849794

Possible mechanisms of morphine analgesia.

J Lipp1.   

Abstract

The body has an endogenous analgesic system that prevents excess pain from interfering with the normal body functions. Depression of pain sensations occurs within the dorsal horn of the spinal cord where the primary pain fibers, which transmit pain sensations from the periphery, synapse with neurons that transmit pain to the higher centers. There appear to be two mechanisms by which the transmission of pain sensations are depressed; these include hyperpolarization of interneurons within the dorsal cord and depressing the release of the neurotransmitters associated with pain transmission. Activation of the analgesic mechanisms results from an interaction between specific neurotransmitters, such as enkephalin, serotonin, or norepinephrine, and specific receptors located on the neurons that transmit pain. The spinal analgesic mechanisms can be activated by either pain or nonpainful sensations arriving from the periphery or by supraspinal mechanisms. The supraspinal mechanisms originate in specific structures within the brainstem that include the periaqueductal gray matter, locus ceruleus, and nuclei in the medulla. These systems are activated either by ascending pain impulses or by higher centers such as the cortex or hypothalamus that, in turn, activate the spinal analgesic systems. There are three systems associated with activation of the supraspinal mechanisms. These include the opioid system associated with the release of the endorphins, the adrenergic system associated with the release of norepinephrine, and the serotonergic system associated with the release of serotonin. The interaction between these systems activates the spinal analgesic system. When the endogenous analgesic systems fail to control pain, analgesic drugs can be used to enhance the endogenous systems. Opiate drugs, such as morphine, interact with opioid receptors and produce analgesia by the same mechanisms as enkephalin, i.e., hyperpolarization of interneurons and depressing the release of transmitters associated with transmission of pain. In addition, morphine can interact with opioid receptors located in the supraspinal structures and activate the supraspinal system. Adrenergic drugs that interact with specific receptors also produce analgesia and it has been suggested that morphine interacts with the adrenergic system to produce analgesia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849794     DOI: 10.1097/00002826-199104000-00003

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  24 in total

1.  Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the rat Ventrolateral Periaqueductal Gray.

Authors:  Tao Chen; Jing Li; Ban Feng; Rui Hui; Yu-Lin Dong; Fu-Quan Huo; Ting Zhang; Jun-Bin Yin; Jian-Qing Du; Yun-Qing Li
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

2.  Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.

Authors:  Dioneia Araldi; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2019-06-17       Impact factor: 6.167

3.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

4.  Tramadol hydrochloride--not just another opioid agonist.

Authors:  K Eggers; I Power
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

5.  Electrophysiological actions of alfentanil: intracellular studies in the rat locus coeruleus neurones.

Authors:  T H Chiu; M H Yeh; S K Tsai; M S Mok
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Intracerebroventricular opiate infusion for refractory head and facial pain.

Authors:  Darrin J Lee; Gene G Gurkoff; Amir Goodarzi; J Paul Muizelaar; James E Boggan; Kiarash Shahlaie
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

Review 7.  Propiram. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use as an analgesic.

Authors:  Karen L Goa; Rex N Brogden
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

8.  Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol.

Authors:  Valentina Ruggieri; Giovanni Vitale; Luigi Alberto Pini; Maurizio Sandrini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-11       Impact factor: 3.000

9.  Desensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents.

Authors:  D Smart; D G Lambert
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 10.  Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.

Authors:  J C Gillis; P Benfield; K L Goa
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.